Assignee
THEAPRIN PHARMACEUTICALS INC
US·9 granted patents·13 pending applications·19 citations·filing 2012–2024
Top patents by PatentIndex Score
22 records- 0194US9603937B2Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2015·Granted Mar 28, 2017·6 cites·3 claims
- 0290US9603938B2Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·3 cites·3 claims
- 0389US12268783B2Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2021·Granted Apr 8, 2025·1 cites·4 claims
- 0489US9603939B2Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·3 cites·3 claims
- 0588US2025228778A1Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0681US9289440B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2014·Granted Mar 22, 2016·2 cites·14 claims
- 0781US8685948B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2013·Granted Apr 1, 2014·2 cites·16 claims
- 0880US8476250B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2013·Granted Jul 2, 2013·2 cites·24 claims
- 0976US2025134912A1Compositions comprising cocrystals of acetylsalicylic acid and theanine with tromethamine and methods of useTHEAPRIN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1075US2023111210A1Cocrystal antioxidants of protocatechuic acid with l-theanine for the treatment of oxidative stress and inflammatory conditionsTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1175US2023115710A1Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, sodium bicarbonate ,and l-theanine for the treatment of acute myocardial infarctionTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1275US2023201147A1Cocrystal antioxidants of protocatechuic acid with l-theanine for the treatment of oxidative stress and inflammatory conditionsTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1375US2023201152A1Cocrystal antioxidants of protocatechuic acid with l-theanine for the treatment of oxidative stress and inflammatory conditionsTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1475US2023110872A1Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, sodium bicarbonate, and l-theanine for the treatment of acute myocardial infarctionTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1571US2023149427A1Compositions comprising cocrystals of acetylsalicylic acid and theanine with tromethamine and methods of useTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1667US2014296189A1Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1767US2014343021A1Adjuvant to thrombolytic therapy for the treatment of frostbiteTHEAPRIN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1867US2014235594A1Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1964US2020101010A1Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, sodium bicarbonate, and l-theanine for the treatment of acute myocardial infarctionTHEAPRIN PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2063US10376464B2Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2016·Granted Aug 13, 2019·0 cites·12 claims
- 2163US2013012482A1Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2261US9896411B2Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2016·Granted Feb 20, 2018·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when THEAPRIN PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →